ResearcherShanghai Changzheng HospitalActive in the last 2 years

Tuo Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6691-7423; OpenAlex author ID A5100721492. Sources: ClinicalTrials.gov.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 1
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 trial

Papers 1

Pancreatic cancer: challenges and opportunities. First author DOI 10.1186/s12916-018-1215-3 ↗

Trials 1

Pancreatic Cancer and Diabetes Mellitus Study director NCT06585072 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Min Li · 1 shared paper, 2018 · strength 0.12
- Paper Pancreatic cancer: challenges and opportunities. DOI 10.1186/s12916-018-1215-3 ↗
Yiqi Du · 1 shared paper, 2018 · strength 0.12
- Paper Pancreatic cancer: challenges and opportunities. DOI 10.1186/s12916-018-1215-3 ↗
Huiyun Zhu · 1 shared paper, 2018 · strength 0.12
- Paper Pancreatic cancer: challenges and opportunities. DOI 10.1186/s12916-018-1215-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.